Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Evofem Bioscience Inc (EVFM)

Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Evofem Bioscience Inc 7770 Regents Rd Suite 113-618 SAN DIEGO CA 92122 USA

www.evofem.com Employees: 32 P: 858-550-1900

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Evofem Biosciences Inc. develops and anticipates commercializing products which support and promote women as the primary healthcare consumer. The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention of acquisition of sexually transmitted infections and products which address or promote general health and wellbeing. Evofem Biosciences Inc., formerly known as Neothetics Inc., is based in SAN DIEGO CA.

Key Statistics

Overview:

Market Capitalization, $K 1,180
Enterprise Value, $K 5,360
Shares Outstanding, K 132,530
Float, K 132,517
% Float 99.99%
Short Interest, K 7
Short Float 0.01%
Days to Cover 1.00
Short Volume Ratio 0.87
% of Insider Shareholders 0.01%
% of Institutional Shareholders 0.22%

Financials:

Annual Sales, $ 19,360 K
Annual Net Income, $ -8,860 K
Last Quarter Sales, $ 4,950 K
Last Quarter Net Income, $ -1,570 K
EBIT, $ -240 K
EBITDA, $ 410 K

Growth:

1-Year Return 4.82%
3-Year Return -99.50%
5-Year Return -100.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.01 on 11/13/25
Next Earnings Date 03/23/26 [--]
Earnings Per Share ttm -0.06
EPS Growth vs. Prev Qtr 50.00%
EPS Growth vs. Prev Year 50.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-125 on 05/18/23

EVFM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -33.51%
Profit Margin % -45.76%
Debt/Equity 0.00
Price/Sales 0.43
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.55
Interest Coverage -0.57
60-Month Beta -1.41
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar